The effect of antimicrobial agents on bilirubin binding by human erythrocytes.
D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001663:Bilirubin / Q000378:metabolism*; D002228:Carbenicillin / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D003023:Cloxacillin / Q000494:pharmacology; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism*; D004917:Erythromycin / Q000494:pharmacology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007612:Kanamycin / Q000494:pharmacology; D009675:Novobiocin / Q000494:pharmacology; D010118:Oxytetracycline / Q000494:pharmacology; D010400:Penicillin G / Q000494:pharmacology; D010404:Penicillin V / Q000031:analogs & derivatives / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects*; D012980:Sodium Salicylate / Q000494:pharmacology*; D013307:Streptomycin / Q000494:pharmacology; D013411:Sulfadiazine / Q000494:pharmacology; D013424:Sulfanilamides / Q000494:pharmacology; D013432:Sulfathiazoles / Q000494:pharmacology; D013444:Sulfisoxazole / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology*; D013752:Tetracycline / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D013424:Sulfanilamides; D013432:Sulfathiazoles; D013449:Sulfonamides; D013411:Sulfadiazine; D009675:Novobiocin; D007612:Kanamycin; D004917:Erythromycin; D002701:Chloramphenicol; D013444:Sulfisoxazole; D000667:Ampicillin; D013752:Tetracycline; D002228:Carbenicillin; D003023:Cloxacillin; D010400:Penicillin G; D001663:Bilirubin; D012980:Sodium Salicylate; D010118:Oxytetracycline; D013307:Streptomycin; D010404:Penicillin V